SCHEMBL4535391

SCHEMBL4535391

C#CCCC=CC(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.54
MAOB P27338 2/20 0.52
EPHX2 P34913 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
KIF11 P52732 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
KCNJ5 P48544 1/20 0.42
KCNJ3 P48549 1/20 0.42
PSMB11 A5LHX3 1/20 0.42
PSMA7 O14818 1/20 0.42
PSMB1 P20618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9943583 0.83 TGM2 (0.56) TGM2MAOBEPHX2CA12CA1
SCHEMBL5713228 0.81 TGM2 (0.51) TGM2MAOBEPHX2CA12CA1
SCHEMBL19280682 0.74 TGM2 (0.65) TGM2MAOBEPHX2CA12CA1
SCHEMBL13174972 0.74 ALDH1A1 (0.68) TGM2MAOBEPHX2ALDH1A1MEN1
SCHEMBL16742068 0.74 TGM2 (0.65) TGM2MAOBEPHX2CA12CA1
SCHEMBL5713229 0.74 TGM2 (0.52) TGM2MAOBEPHX2CA12CA1
SCHEMBL13113128 0.73 TGM2 (0.63) TGM2MAOBEPHX2CA12CA1
SCHEMBL13174657 0.73 ALDH1A1 (0.68) TGM2MAOBEPHX2CA12CA1
SCHEMBL27767027 0.72 TGM2 (0.71) TGM2MAOBEPHX2CA12CA1
SCHEMBL5142584 0.71 EPHX2 (0.70) TGM2EPHX2KIF11NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed